FDA Warning Letter — SoloVital

Case 688046 — FEI 3030905367

The FDA took a Warning Letter action against SoloVital on Aug 27, 2024 (Chula Vista, CA). The action was issued by CDER and concerns drugs products.

Action Details

Facility
SoloVital
Date
Aug 27, 2024
Fiscal Year
2024
Product Type
Drugs
Center
CDER
Location
Chula Vista, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.